Fibrocell Science (FCSC) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fibrocell Science, Inc.  (FCSC)


Fibrocell Science's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Fibrocell Science's ROA in the third quarter of 2019?
Fibrocell Science, Inc. recorded a cumulative net loss of $-1 million during 12 months ending in the third quarter of 2019, resulting in a negative return on assets (ROA) of -5.47%.

However, within the Healthcare sector 254 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2019 from 389 to 3352.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Total Assets Change 57.2 % 101.74 % 28.21 % -18.82 % 28.44 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -1 3 -12 -11 -6
Return On Assets (TTM) -5.47 % 14.08 % -67.22 % -66.52 % -36.47 %
FCSC's Total Ranking # 3352 # 389 # 4531 # 4985 # 4150
Total Assets (TTM) in million 28 35 18 16 18
Seq. Total Assets Change -20.17 % 92.2 % 15.08 % -10.98 % 2.45 %
Seq. Net Income Change - - - - -

FCSC's 5 Years Annual ROA >> Back to FCSC Management Effectiveness >> Compare FCSC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 87
Sector # 255
Overall # 3225

Return On Assets Statistics
High Average Low
14.08 %
-76.98 %
-143.82 %
(Jun 30 2019)   (Sep 30 2017)





Financial Statements
Fibrocell Science's Assets $ 28 million FCSC's Balance sheet
Fibrocell Science's Income $ -7 million Quarterly FCSC's Income Statement
FCSC's Income by Division See FCSC's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change -18.82 % -0.87 % -46.66 % -19.55 % -33.88 %
Total Assets in million 16 19 20 37 46
Y / Y Net Income Change - - - - -
Net Income in million -11 -20 -15 -34 -26
Annual Return On Assets -68.47 % -104.78 % -78.09 % -93.85 % -56.21 %

FCSC's 5 Years Annual ROA >> Back to FCSC Management Effectiveness >> Compare FCSC ROA to its Competitors



More Return On Assets Ratios
FCSC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FCSC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FCSC's Competitors
Subscribers only: Roa for Fibrocell Science's Suppliers
Subscribers only: Return On Assets for FCSC's Customers

You may also want to know
FCSC's Roi FCSC's Inventory Turnover Ratio FCSC's Growth Rates FCSC's Dividend Comparisons
FCSC's Profitability Ratios FCSC's Asset Turnover Ratio FCSC's Dividend Growth
FCSC's Roe FCSC's Valuation Ratios FCSC's Financial Strength Ratios FCSC's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector ROA

Date modified: 2026-09-08T15:09:43+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.